Velia
Seung Woo is currently working as an Associate Director at Velia, having previously held positions as a Principal Scientist at Takeda and GNF. With a strong background in research, Seung Woo led drug discovery projects focusing on RNA splicing in neurodegeneration and cancer. Prior to this, Seung Woo conducted postdoctoral research at Scripps Research, focusing on somatosensory mechanotransduction. Seung Woo also conducted skin stem/progenitor cell research during their Ph.D. thesis research at Columbia University in the City of New York. Additionally, Seung Woo worked as a tissue bank coordinator at Johns Hopkins School of Medicine, assisting in collecting and banking breast cancer specimens.
This person is not in any teams
This person is not in any offices
Velia
Velia is an emerging biotech harnessing the broad therapeutic potential of a newly identified, yet abundant class of human proteins. Transformational work from Velia founders revealed that many of those previously overlooked proteins regulate biological functions vital to human health. Velia will discover and develop therapeutics targeting these novel regulators.